General Information
Version
1.03
Revision date
2025-05-08
Product name
CATIONIC ADDITIF CA151A
1.2.1 Relevant identified uses
Industrial applications
1.2.2. Uses advised against
Product is not intended, labelled or packaged for consumer use
Emergency telephone
+48338517298, +48338517100
Icons in SDS
Company Information
company name
PPG Cieszyn SA
e-mail address of the competent person responsible for the Safety Data Sheet
Product.Stewardship.EMEA@ppg.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H336
Hazard statements
Code
Statements
H336
May cause drowsiness or dizziness
Section 2
SECTION 2: Hazards identification
Classification of the substance or mixture
Product definition
Mixture Classification according to UK CLP/GHS STOT SE 3, H336
Signal word
Warning
Hazard statements
May cause drowsiness or dizziness.
Prevention
Avoid breathing vapour.
Response
IF INHALED: Call a POISON CENTER or doctor if you feel unwell.
Storage
Store in a well-ventilated place. Keep container tightly closed.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations. P261, P304 + P312, P403 + P233, P501
Supplemental label elements
Not applicable. elements
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
Not applicable.
Special packaging requirements
Containers to be fitted Not applicable. with child-resistant fastenings
Tactile warning of danger
Not applicable.
2.3 Other hazards
Product meets the criteria This mixture does not contain any substances that are assessed to be a PBT or a for PBT or vPvB according vPvB. to Regulation (EC) No.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to UK CLP/GHS STOT SE 3, H336 The product is classified as hazardous according to UK CLP Regulation SI 2019/720 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
